{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:52:00Z","timestamp":1772121120260,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jinf.2021.02.015","type":"journal-article","created":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T02:37:07Z","timestamp":1613356627000},"page":"384-390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Optimal symptom combinations to aid COVID-19 case identification: Analysis from a community-based, prospective, observational cohort"],"prefix":"10.1016","volume":"82","author":[{"given":"M.","family":"Antonelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Capdevila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Chaudhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Granerod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.S.","family":"Canas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.S.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Klaser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Modat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Molteni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.H.","family":"Sudre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"May","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.H.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.A.","family":"Drew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.T.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P.","family":"Cramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Spector","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ourselin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.J.","family":"Steves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.E.","family":"Loeliger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2021.02.015_bib0001","article-title":"What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2","author":"Hodgson","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"6494","key":"10.1016\/j.jinf.2021.02.015_bib0002","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1126\/science.abc5312","article-title":"A strategic approach to COVID-19 vaccine R&D","volume":"368","author":"Corey","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jinf.2021.02.015_bib0003","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine","author":"Polack","year":"2020","journal-title":"New Eng J Med"},{"key":"10.1016\/j.jinf.2021.02.015_bib0004","unstructured":"Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine: https:\/\/investors.modernatx.com\/node\/10421\/pdf [Accessed 9th December 2020]."},{"key":"10.1016\/j.jinf.2021.02.015_bib0005","unstructured":"AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19: https:\/\/www.astrazeneca.com\/media-centre\/press-releases\/2020\/azd1222hlr.html [Accessed 9th December 2020]."},{"key":"10.1016\/j.jinf.2021.02.015_bib0006","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2147\/CLEP.S276825","article-title":"Three quarters of people with SARS-CoV-2 infection are asymptomatic: analysis of english household survey data","volume":"12","author":"Petersen","year":"2020","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jinf.2021.02.015_bib0007","first-page":"e2179","article-title":"Comparison of influenza type A and B with COVID-19: a global systematic review and meta-analysis on clinical, laboratory and radiographic findings","author":"Pormohammad","year":"2020","journal-title":"Rev Med Virol"},{"issue":"8","key":"10.1016\/j.jinf.2021.02.015_bib0008","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jinf.2021.02.015_bib0009","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000509143","article-title":"Predictive value of sudden olfactory loss in the diagnosis of COVID-19","volume":"82","author":"Haehner","year":"2020","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"10.1016\/j.jinf.2021.02.015_bib0010","unstructured":"A Phase 3, Randomised, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Adults Aged 18 Years and Older. https:\/\/www.modernatx.com\/sites\/default\/files\/mRNA-1273-P301-Protocol.pdf"},{"key":"10.1016\/j.jinf.2021.02.015_bib0011","unstructured":"A phase 1\/2\/3, placebo-controlled, randomised, observer-blind, dose-finding study to evaluate the safety, tolerability, immunogenicity, and efficacy of SARS-CoV-2 RNA vaccine candidates against COVID-19 in healthy. individuals https:\/\/pfe-pfizercom-d8-prod.s3.amazonaws.com\/2020-09\/C4591001_Clinical_Protocol_0.pdf"},{"key":"10.1016\/j.jinf.2021.02.015_bib0012","unstructured":"A. Randomised, Double-blind, Placebo-controlled Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older. https:\/\/www.jnj.com\/coronavirus\/covid-19-phase-3-study-clinical-protocol"},{"key":"10.1016\/j.jinf.2021.02.015_bib0013","unstructured":"A Phase III Randomized, Double-blind, Placebo-controlled Multicenter Study in Adults to Determine the Safety, Efficacy, and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, for the Prevention of COVID-19. https:\/\/s3.amazonaws.com\/ctr-med-7111\/D8110C00001\/52bec400-80f6-4c1b-8791-0483923d0867\/c8070a4e-6a9d-46f9-8c32-cece903592b9\/D8110C00001_CSP-v2.pdf"},{"key":"10.1016\/j.jinf.2021.02.015_bib0014","unstructured":"A Phase 3, Randomised, Observer-blinded, Placebo-Controlled Trial to evaluate the Efficacy and Safety of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-RS) with Matrix-M1 Adjuvant in Adult participants 18-84 years of Age in the United Kingdom. https:\/\/www.novavax.com\/download\/files\/protocols\/2019nCoV302Phase3UKVersion2FinalCleanRedacted.pdf"},{"key":"10.1016\/j.jinf.2021.02.015_bib0015","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","author":"Voysey","year":"2020","journal-title":"Lancet"},{"issue":"6497","key":"10.1016\/j.jinf.2021.02.015_bib0016","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.abc0473","article-title":"Rapid implementation of mobile technology for real-time epidemiology of COVID-19","volume":"368","author":"Drew","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jinf.2021.02.015_bib0017","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1109\/4235.996017","article-title":"A fast and elitist multi-objective genetic algorithm: NSGA-II IEEE","volume":"6","author":"Deb","year":"2002","journal-title":"Trans Evol Comput"},{"key":"10.1016\/j.jinf.2021.02.015_bib0018","article-title":"Symptom clusters in Covid19: a potential clinical prediction tool from the COVID Symptom study App.","author":"Sudre","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jinf.2021.02.015_bib0019","unstructured":"Clinical Management of COVID-19 (WHO interim guidance): https:\/\/www.who.int\/publications\/i\/item\/clinical-management-of-covid-19 (Accessed November 22, 2020)."},{"issue":"8","key":"10.1016\/j.jinf.2021.02.015_bib0020","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.mayocp.2020.05.030","article-title":"Smell and taste dysfunction in patients with COVID-19: a systematic review and meta-analysis","volume":"95","author":"Agyeman","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jinf.2021.02.015_bib0021","unstructured":"Public Health England. https:\/\/www.gov.uk\/government\/publications\/wuhan-novel-coronavirus-initial-investigation-of-possible-cases\/investigation-and-initial-clinical-management-of-possible-cases-of-wuhan-novel-coronavirus-wn-cov-infection#criteria (Accessed December 11th 2020)."},{"issue":"7","key":"10.1016\/j.jinf.2021.02.015_bib0022","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/s41591-020-0916-2","article-title":"Real-time tracking of self-reported symptoms to predict potential COVID-19","volume":"26","author":"Menni","year":"2020","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.jinf.2021.02.015_bib0023","doi-asserted-by":"crossref","first-page":"e21956","DOI":"10.2196\/21956","article-title":"App-based tracking of self-reported COVID-19 symptoms: analysis of questionnaire data","volume":"22","author":"Zens","year":"2020","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.jinf.2021.02.015_bib0024","article-title":"Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: results from a statewide epidemiological study.","author":"Dixon","year":"2020","journal-title":"medRxiv"},{"issue":"5","key":"10.1016\/j.jinf.2021.02.015_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008536","article-title":"The hallmarks of COVID-19 disease","volume":"16","author":"Tang","year":"2020","journal-title":"PLoS Pathog"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445321000797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445321000797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:30:08Z","timestamp":1759008608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445321000797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0163445321000797"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2021.02.015","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.11.23.20237313","asserted-by":"object"}]},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimal symptom combinations to aid COVID-19 case identification: Analysis from a community-based, prospective, observational cohort","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2021.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}]}}